Trial: 201512009

A Phase I and Pilot Study of the Effects of rhIL-7-hyFc (NT-17) on CD4 Counts in Patients with High Grade Gliomas and Severe Treatment-Related CD4 Lymphopenia after Concurrent Radiation and Temozolomide

Phase

I

Principal Investigator

Chheda, Milan

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov